MAPS
Dead / Abandoned — Abandoned — failure to respond (as of 20 May 2024)
What this means for you
This application is over — abandoned 07 May 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88985287
- Mark type
- Stylized text
- Filed
- 18 Oct 2019
- Published for opposition
- 05 Jan 2021
- Abandoned
- 07 May 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 042 — Scientific and technological services: research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein-based antigens; research and development in the field of vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens
Owner
- Affinivax, Inc., Wilmington, DE, US
- Affinivax, Inc., Lexington, MA, US
Prosecution history
- 20 May 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 20 May 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 01 Feb 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 01 Feb 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 06 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Nov 2023 — NON-FINAL ACTION E-MAILED
- 06 Nov 2023 — SU - NON-FINAL ACTION - WRITTEN
- 03 Oct 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Sept 2023 — USE AMENDMENT FILED
- 03 Oct 2023 — DIVISIONAL PROCESSING COMPLETE
- 22 Sept 2023 — DIVISIONAL REQUEST RECEIVED
- 22 Sept 2023 — TEAS REQUEST TO DIVIDE RECEIVED
- 22 Sept 2023 — TEAS STATEMENT OF USE RECEIVED
- 12 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2023 — SOU EXTENSION 5 GRANTED